Skip to content
Recall Observatory FDA recall evidence

Drug product

Moxifloxacin Ophthalmic Solution, 0.5%, 3 mL, Rx Only, Packaged and Distributed By: Direct Rx, LLC 94 Worldwide Drive, Dawsonville, GA 30534, NDC 72189-0334-05

D-0101-2023

November 02, 2022

Class II

Product summary

Firm
Direct Rx
Event
Event 91114
Status
Terminated
Classification
Class II
Quantity
11 bottles
Official record key
drug-enforcement:D-0101-2023

Official wording

Reason: cGMP deviation: discontinue of stability support for product.

Code information: Lot #: 07MA2232, Exp. 4/30/23

Distribution pattern: FL

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP deviation